Roche to seek early FDA approval for Alzheimer’s therapy: Jefferies

After a meeting with the FDA late last week, Swiss drugmaker Roche (OTCQX:RHHBY) has discussed internally to target an “expedited” U.S. filing of its experimental Alzheimer’s therapy gantenerumab, according to Jefferies.